FIG Financial Advisory Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

FIG Financial Advisory Services's ALNY Position: Q1 2026 in Review

FIG Financial Advisory Services sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2026, closing a stake of 2,845 shares — an estimated $1.13M sold.

FIG Financial Advisory Services first reported a position in ALNY in Q3 2025 and held it in 2 quarters. The position peaked at $1.28M in Q3 2025. 791 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

• FIG Financial Advisory Services reported no remaining Alnylam Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
• FIG Financial Advisory Services sold 2,845 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $1.13M.
• FIG Financial Advisory Services first reported a position in Alnylam Pharmaceuticals in Q3 2025 and held it in 2 quarters.
• FIG Financial Advisory Services's Alnylam Pharmaceuticals position peaked at $1.28M in Q3 2025.
• 791 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on FIG Financial Advisory Services's 13F filing for Q1 2026, filed 10 Aug 2026.